Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC4 | P56524 | 7/20 | 0.60 |
| ▸ | MEF2D | Q14814 | 7/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | EGFR | P00533 | 1/20 | 0.43 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.43 |
| ▸ | SLC6A19 | Q695T7 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | MMP1 | P03956 | 2/20 | 0.43 |
| ▸ | MMP2 | P08253 | 2/20 | 0.43 |
| ▸ | MMP9 | P14780 | 2/20 | 0.43 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.42 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5431345 | 1.00 | HDAC4 (0.60) | HDAC4MEF2DALDH1A1EGFRHDAC3 | |
| SCHEMBL15121425 | 0.84 | CYSLTR2 (0.52) | HDAC4MEF2DALDH1A1EGFRHDAC3 | |
| SCHEMBL15121424 | 0.84 | CYSLTR2 (0.52) | HDAC4MEF2DALDH1A1EGFRHDAC3 | |
| SCHEMBL28089990 | 0.84 | HDAC4 (0.58) | HDAC4MEF2DALDH1A1KDM4EHPGD | |
| SCHEMBL28089992 | 0.84 | HDAC4 (0.58) | HDAC4MEF2DALDH1A1KDM4EHPGD | |
| SCHEMBL19327151 | 0.81 | HDAC3 (0.45) | HDAC4MEF2DALDH1A1EGFRHDAC3 | |
| SCHEMBL5440150 | 0.81 | HDAC3 (0.45) | HDAC4MEF2DALDH1A1EGFRHDAC3 | |
| SCHEMBL5440153 | 0.81 | HDAC3 (0.45) | HDAC4MEF2DALDH1A1EGFRHDAC3 | |
| SCHEMBL30071647 | 0.81 | HDAC3 (0.45) | HDAC4MEF2DALDH1A1EGFRHDAC3 | |
| SCHEMBL5672082 | 0.81 | HDAC4 (0.47) | HDAC4MEF2DMMP1MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070099968-A1 | Antiviral compounds and methods | BIOTRON LIMITED (AU) | 2007-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070099968-A1 | Antiviral compounds and methods | MAVS, ZC3HAV1, EIF2AK2 | HDAC4 366/4885MEF2D 4268/4885ALDH1A1 3221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.